IP Library Granted Patent US 10,202,417
Granted Patent B2
US 10,202,417 · App. 14/776,622 · Granted Feb 12, 2019

Purification method for vitamin K dependent proteins by anion exchange chromatography

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,202,417
App. No.
14/776,622
Granted
Feb 12, 2019
Kind
B2
Abstract

The present invention relates to a method for the purification of Vitamin K dependent proteins with high yield and high purity, particularly enriched in active protein, on anion exchange resin materials, to Vitamin K dependent proteins obtainable by said method, and to a kit comprising means for carrying out said method.

Claims (18)

1. A method for the purification of an active Vitamin K-dependent protein comprising the steps of:

(a) loading a first anion exchange resin material with the Vitamin K-dependent protein in a loading buffer in the absence or low concentration of divalent cations;

(b) performing at least three washing steps with washing buffers that are absent of said divalent cations but that contain counter anions,

wherein the first washing buffer has a pH between 6.8 and 7.5, the second washing buffer has a pH between 5.5 and 6.5, and the third washing buffer has a pH between 7.0 and 8.2,

(c) eluting the Vitamin K-dependent protein with an eluant comprising 1-3 mM calcium and a counter-anion to form an eluate containing the active Vitamin K dependent protein, wherein

the eluant has a conductivity between 15 and 22 mS/cm (25° C.), and

a pH of between 7.0 and 9.0;

(d) diluting the obtained eluate pool, and increasing the concentration of the calcium,

(e) loading a second anion exchange resin material with the diluted eluate pool as obtained after step (c); and

(f) collecting the flow-through containing the active Vitamin K-dependent protein.

2. The method according claim 1 , wherein the first and second anion exchange resin materials each have a positively charged group which is independently selected from the group, consisting of diethylaminoethane (DEAE), dimethylaminoethane (DMAE), trimethylaminoethyl (TMAE), polyethyleneimine (PEI), quaternary aminoalkyl, quaternary aminoethane (QAE), and quaternary ammonium (Q).

3. The method according to claim 1 , wherein the active Vitamin K-dependent protein is selected from the group consisting of Factor II, Factor VII, Factor IX, Factor X, Protein C, and Protein S.

4. The method according to claim 1 , wherein the elution buffer in step (b) further comprises 180 mM NaCl.

5. The method according to claim 1 , wherein step (c) includes diluting the obtained eluate pool to lower the conductivity.

6. The method according to claim 3 , wherein the active Vitamin K-dependent protein is Factor IX.

7. The method according to claim 1 , wherein in step (c) the eluant comprises 2 mM calcium and the counter-anion.

8. The method according to claim 1 , wherein in step (c) the eluant has a conductivity between 16.9 to 22 mS/cm (25° C.).

9. The method according to claim 1 , wherein in step (b) the second washing buffer has a pH between 5.9 and 6.1.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0238 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2015
From: MITTERER, ARTUR; HASSLACHER, MEINHARD; FIEDLER, CHRISTIAN; MITTERGRADNEGGER, DOMINIK
To: BAXALTA INCORPORATED; BAXALTA GMBH
Reel/Frame 037005/0956 →